Clinical Characteristics, Molecular Profile, and Outcomes in Indian Patients with Glutaric Aciduria Type 1.

IF 0.4 Q4 PEDIATRICS
Journal of pediatric genetics Pub Date : 2021-09-01 Epub Date: 2020-09-02 DOI:10.1055/s-0040-1715528
Parag M Tamhankar, Lakshmi Vasudevan, Pratima Kondurkar, Sarfaraj Niazi, Rita Christopher, Dhaval Solanki, Pooja Dholakia, Mamta Muranjan, Mahesh Kamate, Umesh Kalane, Jayesh Sheth, Vasundhara Tamhankar, Reena Gulati, Madhavi Vasikarla, Sumita Danda, Shaik M Naushad, Katta M Girisha, Shekhar Patil
{"title":"Clinical Characteristics, Molecular Profile, and Outcomes in Indian Patients with Glutaric Aciduria Type 1.","authors":"Parag M Tamhankar,&nbsp;Lakshmi Vasudevan,&nbsp;Pratima Kondurkar,&nbsp;Sarfaraj Niazi,&nbsp;Rita Christopher,&nbsp;Dhaval Solanki,&nbsp;Pooja Dholakia,&nbsp;Mamta Muranjan,&nbsp;Mahesh Kamate,&nbsp;Umesh Kalane,&nbsp;Jayesh Sheth,&nbsp;Vasundhara Tamhankar,&nbsp;Reena Gulati,&nbsp;Madhavi Vasikarla,&nbsp;Sumita Danda,&nbsp;Shaik M Naushad,&nbsp;Katta M Girisha,&nbsp;Shekhar Patil","doi":"10.1055/s-0040-1715528","DOIUrl":null,"url":null,"abstract":"<p><p>Glutaric acidemia type 1 (GA-1, OMIM 231670) is an autosomal recessive inborn error of metabolism caused by the deficiency of glutaryl-coenzyme A (CoA) dehydrogenase with most children presenting in infancy with encephalopathy, dystonia, and macrocephaly. In this article, we presented the clinical characteristics, molecular profile, and outcomes in 29 unrelated families with affected children (30 cases total). The mean age at onset of illness was 10 months (±14.58), whereas the mean age at referral for molecular diagnosis was 29.44 months (±28.11). Patients were residents of nine different states of India. Clinical presentation varied from acute encephalitis followed by neuroregression and chronic/insidious developmental delay. Neurological sequelae varied from asymptomatic (no sequelae, 2 patients) to moderate (5 patients) and severe (23 patients) sequelae. All patients underwent blood tandem mass spectrometry (TMS on dried blood spots) and/or urine gas chromatography mass spectrometry (GCMS). Neuroimaging demonstrated batwing appearance in 95% cases. Sanger's sequencing of <i>GCDH</i> , covering all exons and exon-intron boundaries, was performed for all patients. Variants identified include 15 novel coding variants: p.Met100Thr, p.Gly107Ser, p.Leu179Val, p.Pro217Ser, p. Phe236Leufs*107, p.Ser255Pro, p.Met266Leufs*2, p.Gln330Ter, p.Thr344Ile, p.Leu345Pro, p.Lys377Arg, p.Leu424Pro, p.Asn373Lys, p.Lys377Arg, p.Asn392Metfs*9, and nine known genetic variants such as p.Arg128Gln, p.Leu179Arg, p.Trp225Ter, p.Met339Val, p.Gly354Ser, p.Arg402Gln, p.Arg402Trp, p.His403Tyr, and p.Ala433Val (Ensembl transcript ID: ENST00000222214). Using in silico analysis, genetic variants were shown to be affecting the residues responsible for homotetramer formation of the glutaryl-CoA dehydrogenase protein. Treatment included oral carnitine, riboflavin, protein-restricted diet, lysine-deficient special formulae, and management of acute crises with intravenous glucose and hydration. However, the mortality (9/30, 27.58%) and morbidity was high in our cohort with only two patients affording the diet. Our study is the largest multicentric, genetic variant-proven series of glutaric aciduria type 1 from India till date.</p>","PeriodicalId":16695,"journal":{"name":"Journal of pediatric genetics","volume":"10 3","pages":"213-221"},"PeriodicalIF":0.4000,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1055/s-0040-1715528","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of pediatric genetics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-0040-1715528","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/9/2 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 4

Abstract

Glutaric acidemia type 1 (GA-1, OMIM 231670) is an autosomal recessive inborn error of metabolism caused by the deficiency of glutaryl-coenzyme A (CoA) dehydrogenase with most children presenting in infancy with encephalopathy, dystonia, and macrocephaly. In this article, we presented the clinical characteristics, molecular profile, and outcomes in 29 unrelated families with affected children (30 cases total). The mean age at onset of illness was 10 months (±14.58), whereas the mean age at referral for molecular diagnosis was 29.44 months (±28.11). Patients were residents of nine different states of India. Clinical presentation varied from acute encephalitis followed by neuroregression and chronic/insidious developmental delay. Neurological sequelae varied from asymptomatic (no sequelae, 2 patients) to moderate (5 patients) and severe (23 patients) sequelae. All patients underwent blood tandem mass spectrometry (TMS on dried blood spots) and/or urine gas chromatography mass spectrometry (GCMS). Neuroimaging demonstrated batwing appearance in 95% cases. Sanger's sequencing of GCDH , covering all exons and exon-intron boundaries, was performed for all patients. Variants identified include 15 novel coding variants: p.Met100Thr, p.Gly107Ser, p.Leu179Val, p.Pro217Ser, p. Phe236Leufs*107, p.Ser255Pro, p.Met266Leufs*2, p.Gln330Ter, p.Thr344Ile, p.Leu345Pro, p.Lys377Arg, p.Leu424Pro, p.Asn373Lys, p.Lys377Arg, p.Asn392Metfs*9, and nine known genetic variants such as p.Arg128Gln, p.Leu179Arg, p.Trp225Ter, p.Met339Val, p.Gly354Ser, p.Arg402Gln, p.Arg402Trp, p.His403Tyr, and p.Ala433Val (Ensembl transcript ID: ENST00000222214). Using in silico analysis, genetic variants were shown to be affecting the residues responsible for homotetramer formation of the glutaryl-CoA dehydrogenase protein. Treatment included oral carnitine, riboflavin, protein-restricted diet, lysine-deficient special formulae, and management of acute crises with intravenous glucose and hydration. However, the mortality (9/30, 27.58%) and morbidity was high in our cohort with only two patients affording the diet. Our study is the largest multicentric, genetic variant-proven series of glutaric aciduria type 1 from India till date.

印度1型戊二酸尿患者的临床特征、分子特征和预后
1型戊二酸血症(GA-1, OMIM 231670)是由戊二酰辅酶A (CoA)脱氢酶缺乏引起的常染色体隐性先天性代谢错误,大多数儿童在婴儿期表现为脑病、肌痉挛障碍和大头畸形。在这篇文章中,我们介绍了29个有患病儿童的非亲属家庭(共30例)的临床特征、分子特征和结果。平均发病年龄为10个月(±14.58),转介分子诊断的平均年龄为29.44个月(±28.11)。患者是印度九个不同邦的居民。临床表现从急性脑炎到神经退化和慢性/隐匿性发育迟缓不等。神经系统后遗症从无症状(2例无后遗症)到中度(5例)和重度(23例)后遗症不等。所有患者均接受了血液串联质谱法(TMS)和/或尿液气相色谱质谱法(GCMS)。神经影像学显示95%的病例出现蝙蝠翼。对所有患者进行GCDH的Sanger测序,覆盖所有外显子和外显子-内含子边界。已鉴定的变异包括15个新的编码变异:p.Met100Thr、p.p ele107ser、p.p ele179val、p.p pro217ser、p.p Phe236Leufs*107、p.p ser255pro、p.p met266leufs *2、p.p gln330ter、p.p thr344ile、p.p leu345pro、p.p lys377arg、p.p leu424pro、p.p asn373lys、p.p lys377arg、p.p asn392metfs *9,以及9个已知的遗传变异,如p.p arg128gln、p.p leu179arg、p.p trp225ter、p.p met339val、p.p gly354ser、p.p arg402gln、p.p arg402trp、p.p his403tyr和p.p ala433val (Ensembl转录本ID: ENST00000222214)。使用硅分析,遗传变异被证明是影响残基负责形成戊二酰辅酶a脱氢酶蛋白的四聚体。治疗包括口服肉碱、核黄素、限制蛋白质饮食、赖氨酸缺乏特殊配方,以及静脉注射葡萄糖和水合治疗急性危象。然而,在我们的队列中,只有两名患者负担得起这种饮食,死亡率(9/30,27.58%)和发病率很高。我们的研究是迄今为止印度最大的多中心,遗传变异证实的1型戊二酸尿症系列。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
32
期刊介绍: The Journal of Pediatric Genetics is an English multidisciplinary peer-reviewed international journal publishing articles on all aspects of genetics in childhood and of the genetics of experimental models. These topics include clinical genetics, molecular genetics, biochemical genetics, medical genetics, dysmorphology, teratology, genetic counselling, genetic engineering, formal genetics, neuropsychiatric genetics, behavioral genetics, community genetics, cytogenetics, hereditary or syndromic cancer genetics, genetic mapping, reproductive genetics, fetal pathology and prenatal diagnosis, multiple congenital anomaly syndromes, and molecular embryology of birth defects. Journal of Pediatric Genetics provides an in-depth update on new subjects and current comprehensive coverage of the latest techniques used in the diagnosis of childhood genetics. Journal of Pediatric Genetics encourages submissions from all authors throughout the world. The following articles will be considered for publication: editorials, original and review articles, short report, rapid communications, case reports, letters to the editor, and book reviews. The aim of the journal is to share and disseminate knowledge between all disciplines in the field of pediatric genetics. This journal is a publication of the World Pediatric Society: http://www.worldpediatricsociety.org/ The Journal of Pediatric Genetics is available in print and online. Articles published ahead of print are available via the eFirst service on the Thieme E-Journals platform.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信